Non-nucleoside reverse transcriptase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 249/12 (2006.01) A61K 31/4196 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2682637

Compounds of formula (I), wherein R1, R2, R3, R4, R5, X, Y, and Ar are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.

L'invention porte sur des composés de formule (I), dans laquelle R1, R2, R3, R4, R5, X, Y, et Ar sont tels que définis présentement ou sur des sels pharmaceutiquement acceptables de ces composés, qui inhibent la transcriptase inverse du VIH-1 et fournissent un procédé pour la prévention et le traitement d'infections par le VIH-1, et le traitement du SIDA et/ou du syndrome associé du SIDA. La présente invention porte également sur des compositions contenant des composés de formule (I) utiles pour la prévention et le traitement d'infections par le VIH-1 et le traitement du SIDA et/ou du syndrome associé au SIDA.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1998498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.